ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

NMJ. 2020; 9(1): 14-20


A Comparative Study of Interscalene Block Using Dexmedetomidine With Bupivacaine And Clonidine With Bupivacaine.

Laxman N,Murali Chandradhar A,Venkatesh V,Shiny Priyadarshini A,Mushahida SK.




Abstract

OBJECTIVE:
To compare the effects of addition of Clonidine and Dexmedetomidine as an adjunct to Bupivacaine for Interscalene block with respect to onset and duration of sensory and motor block and duration of analgesia.
MATERIALS AND METHODS:
70 patients of ASA 1 &2 scheduled for various orthopaedic surgeries for upper limb under interscalene brachial plexus block were divided into two equal groups(n=35)in a randomised double blinded controlled study .
Group I received 0.5% Bupivacaine (20ml) +Dexmedetomidine(1mcg/kg).
Group II received 0.5% Dupivacaine (20ml) + Clonidine(1mcg/kg).
RESULTS:
The mean onset time of sensory & motor blockade was faster in Dexmedetomidine group. (3.54, 5.40 respectively). The duration of sensory & motor blockade was also prolonged in this group (p value 0.006; &

Key words: Interscalene Block ,Bupivacaine, Dexmedetomidine ,Clonidine, Sensory and Motor blockade.







Bibliomed Article Statistics

19
18
19
18
21
33
19
26
32
40
39
9
R
E
A
D
S

13

11

6

8

9

10

21

17

16

10

32

3
D
O
W
N
L
O
A
D
S
080910111201020304050607
20242025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.